[HTML] mdpi.com

[HTML][HTML] Impact of tumor genomic mutations on thrombotic risk in cancer patients

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - mdpi.com
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …
被引用次数：23 相关文章

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients.

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - search.ebscohost.com
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients.

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - europepmc.org
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …
[PDF] core.ac.uk

[PDF][PDF] Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - Risk Prediction and New Prophylaxis … - core.ac.uk
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …
[PDF] semanticscholar.org

[PDF][PDF] Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - pdfs.semanticscholar.org
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …
[PDF] mdpi.com

[PDF][PDF] Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - cancers - mdpi.com
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - search.proquest.com
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …
[HTML] nih.gov

[HTML][HTML] Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients.

O Leiva, JM Connors, H Al-Samkari - Cancers, 2020 - europepmc.org
Venous thromboembolism (VTE) is common in patients with cancer and is an important
contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated …